$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

자궁근종의 성선자극호르몬분비호르몬 효능제 치료에 있어 생리의 영향

The Effect of Menstration on GnRH Agonist Treatment for the Uterine Myoma

약학회지 = Yakhak hoeji v.51 no.6 , 2007년, pp.402 - 408  
Abstract

The aim of this study was to evaluate the effect of menstration among the influencing factors for the GnRH agonist (as G: depot goserelin 3.6 mg) therapy prior to the planned myomectomy for women who wanted to preserve their fertility. We reviewed total 48 patients. with the G therapy prior to the planned myomectomy from August 1st, 2005 to August 31st, 2006. The patients were classified by the G group (n=28) and the immediate surgery (as S) group (n=20). The G group (n=19) underwent the G therapy for 3 month courses, and then the efficacy was evaluated by menstruation and the myoma volumes. In the G group (n=19), therapy was effective, and the mean age was $32.4{\pm}6.5$ years. After the completion of G therapy, the mean volume of the myoma by ultrasonography was reduced to $85.2{\pm}71.2cm^3$ comparing of $430.6{\pm}248.8cm^3$ at first visit. The 11 patients had menstruation and the rest 8 patients with amenorrhea had less reduced volume of the myoma ($124.05{\pm}79.85cm^3\;v.s.\;329.41{\pm}234.0cm^3$ p<0.05). In the immediate S group, the myoma volumes by sonography was also checked for accuracy (${\alpha}=1.0$). As the result, the initial myoma volume had the positive correlations to the effectiveness with G therapy. However, the occurrence and frequency of the menstruation during the G therapy had a negative correlation. In conclusion, the use of G prior to the planned myomectomy was effective in reducing myoma volume and the menstruation.

참고문헌 (40)

  1. Donnez, J. and Jadoul, E : What are the implications of myomas on fertility? A need for a debate? Hum. Reprod. 17,101 (2002) 
  2. Englund, K., Blanck, A., Gustavsson, I., Lundkvist, U., Sjoblom, P., Norgren, A. and Lindblom, B. : Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadatrophin-releasing hormone treatment. J. Clin. Endocrinol. Metab. 83, 4092 (1998) 
  3. Sadan, O., Ginath, S., Sofer, D., Rotmensch, S., Debby, A., Glezerman, M. and Zakut, H. : The role of tamoxifen in the treatment of symptomatic uterine leiomyomata-a pilot study. Eur. J. Obstet. Gynecol. Reprod. Biol. 96, 183 (2001) 
  4. Perry, C. M. and Brogden, R. N. : Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders. Drugs. 51, 319 (1996) 
  5. Kiiholma, E, Tuimala, R., Kivinen, S., Korhonen, M. and Hagman, E. : Comparison of the gonadotrophin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progesterone add-back therapy in the treatment of endometriosis. Fertil Steril. 64, 903 (1995) 
  6. Kiesel, L. A., Rody, A., Greb, R. R. and Szilagyi, A. : Clinical use of GnRH analogues. Clin. Endocrinol. 56, 677 (2002) 
  7. Ross, R. K., Pike, M. C, Vessey, M. P., Bull, D., Yeates, D. and Casagrande, J. T. : Risk factors for uterine fibroids: reduced risk associated with oral contraceptives [published erratum in BMJ 1986; 293: 1027]. BMJ 293, 359 (1986) 
  8. Marshall, L. M., Spiegelman, D., Goldman, M. B., Manson, J. E., Colditz, G. A., Barbieri, R. L., Stampfer, M. J. and Hunter, D. J. : A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril. 70, 432 (1998) 
  9. Kjerulff, K. H., Langenberg, P., Seidman, J. D., Stolley, R D. and Guzinski, G. M.: Uterine leiomyomas: racial differences in severity, symptoms and age at diagnosis. J. Reprod. Med. 41, 483 (1996) 
  10. 백원민, 정승우, 조성식, 임광호 : 자궁근종의 임상적 고찰. 대한산부회지 20, 1047 (1983) 
  11. Filicori, M., Hall, D. A., Loughlin, J. S., Rivier, J., Vale, W. and Crowley, W. F. Jr.: A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue. Am. J. Obstet. Gynecol. 147, 726 (1983) 
  12. 정진국, 고만석, 정병욱, 이호형, 최호준, 신승권 : 자궁근종에 관한 임상통계학적 고찰. 대한산부회지 41, 210 (1998) 
  13. 유한기 : 자궁근종의 임상병리학적 연구. 대한산부회지 30, 1287 (1987) 
  14. Donnez, J., Nisolle, M., Grandjean, E, Gillerot, S. and Clerckx, E : The role of GnRH agonists in the endoscopic treatment of endometriosis and fibromyomas. Contracept. Fertil Sex. 21, 59 (1993) 
  15. Friedman, A. J., Daly, M., Juneau-Norcross, M., Gleason, R., Rein, M. S. and LeBoff, M. : Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years. Hum. Reprod. 9, 1618 (1994) 
  16. Lethaby, A., Vollenhoven, B. and Sowter, M. : Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane. Database. Syst. Rev. 2, CD000547 (2001) 
  17. 이란옥, 박경일, 김종철, 박무실, 김철, 지정희 : 자궁근종에 대한 임상통계학적 관찰. 대한산부회지 30, 213 (1987) 
  18. Pickersgill, A., Kingsland, C. R., Garden, A. S. and Farquharson, R. G.: Multiple gestation following gonadotrophin releasing hormone therapy for the treatment of minimal endometriosis. Br. J. Obstet. Gynaecol. 101, 260 (1994) 
  19. Stewart, E. A. : Uterine fibroids. Lancet. 357, 293 (2001) 
  20. Paraziini, E, La Vecchia, C, Negri, E., Cecchetti, G. and Fedele, L. : Epidemiologic characteristics of women with uterine fibroids: a case control study. Obstet. Gynecol. 72, 853 (1988) 
  21. 김동호, 김홍관, 선진규, 박병삼, 임헌정 : 자궁근종에 대한 임상 및 병리학적 연구. 대한산부회지 37, 1205 (1994) 
  22. Carr, B. R., Marshburn, E B., Weatherall, E T, Bradshaw, K. D., Breslau, N. A., Byrd, W, Roark, M. and Steinkampf, M. E : An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. J. Clin. Endocrinol. Metab. 76, 1217 (1993) 
  23. Lumsden, M. A. : The effects of steroid hormones on the growth of uterine leiomyomata. In: Motta, M. and Serio, M. eds. Sex hormones and antihormones in endocrine dependent pathology. Basic and clinical aspects. Excerpta Medica (1994) 
  24. 이종학 : 자궁근종에 대한 임상적 및 병리학적 연구. 대한산부회지 30, 213 (1987) 
  25. 육순광, 정기성, 이숙환, 김성도, 안재영 : 자궁근종의 임상병리학적 고찰. 대한산부회지 27, 184 (1984) 
  26. Early breast cancer trialists' collaborative group. Ovarian ablation in early breast cancer: overview of the randomised trials. Lancet. 348, 1189 (1996) 
  27. 서호성, 남철, 김창수, 장병곤, 양희동, 박세준 : 자궁근종에 대한 임상통계학적 연구. 대한산부회지 39, 1047 (1996) 
  28. Cramer, S. E and Patel, A. : The frequency of uterine leiomyomas. Am. J. Clin. Pathol. 94, 435 (1990) 
  29. Garcia, C. R. and Tureck, R. W : Submucosal leiomyomas and infertility. Fertil Steril. 42, 16 (1984) 
  30. West, C. E, Lumsden, M. A., Lawson, S., Williamson, J. and Baird, D. T.: Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril. 48, 45 (1987) 
  31. Donnez, J., Schrurs, B., Gillerot, S., Sandow, J. and Clerckx, E : Treatment of uterine fibroids with implants of gonadotrophin-releasing hormone agonist: assessment by hysterography. Fertil Steril. 51, 947 (1989) 
  32. Jonathan, S. B., Eli, Y. A. and Paula, A. H.: Novak's gynecology 12th. Williams & Wilkins, Baltimore, p. 374 (1996) 
  33. Buttram, V C. Jr. and Reiter, R. C. : Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 36, 433 (1981) 
  34. Rice, J. E, Kay, H. H. and Mahony, B. S. ; The clinical significance of uterine leiomyomas in pregnancy. Am. J. Obstet. Gynecol. 160, 1212 (1989) 
  35. Friedman, A. J., Barbieri, R. L., Doubilet, E M., Fine, C. and Schiff, I. : A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri. Fertil Steril. 49, 404 (1988) 
  36. Cramer, S. F. and Patel, A. : The frequency of uterine leiomyomas. Am. J. Clin. Pathol. 94, 435 (1990) 
  37. Burroughs, K. D., Fuchs-Young, R., Davis, B. and Walker, C. L.: Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. Biol. Reprod. 63, 1322 (2000) 
  38. Marshall, L. M., Spiegelman, D., Barbieri, R. L., Goldman, M. B., Manson, J. E., Colditz, G. A., Willett, W C. and Hunter, D. J. : Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet. Gynecol. 90, 967 (1997) 
  39. Shaw, R. W : New approaches to the management of fibroids. Curr. Opin. Obstet. Gynecol. 3, 859 (1991) 
  40. Stovall, T. G., Muneyyirci-Delale, O., Summit, R. L. Jr. and Scialli, A. R. : GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Obstet. Gynecol. 86, 64 (1995) 

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음

원문보기

원문 PDF 다운로드

  • ScienceON :

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일